Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment
These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients
Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor
The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
In comparison to traditional open-heart surgery, which involves opening up the chest by splitting the breastbone, da Vinci Xi's innovative technology allows for complex cardiovascular surgeries to be performed through smaller incisions and precise motion control
At present 18 per cent of the local pharmaceutical market is under government's price control
This is Omeza’s first Rx product and the first drug/device combination matrix of its kind for chronic wound care
Over 13 million people in Japan suffer from chronic kidney disease and this will transform treatment options
The clinical research organisation located in Hyderabad is a USFDA inspected facility
Researchers from IIT Bombay and QIMR Berghofer Medical Research Institute, Australia have developed this method, based on the Agilent Cary 630 FTIR Spectrometer
Subscribe To Our Newsletter & Stay Updated